BIOMARIN PHARMACEUTICAL INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,740 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page
25
Current page
8
144 File 000-26727

144 filing

Filing date
31 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 May 2024
Reporting date
28 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
29 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
28 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 May 2024
Reporting date
20 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
22 May 2024
Reporting date
20 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 May 2024
Reporting date
20 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 May 2024
Reporting date
17 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 May 2024
Reporting date
09 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
10 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .